AI in Medicine Manual vs AI-Assisted Prescreening for Trial Eligibility Using Large Language Models—A Randomized Clinical Trial Ozan Unlu, MD; Matthew Varugheese, MS; Jiyeon Shin, BS, ALM; et al. Abstract Full Text free access JAMA. Published online February 17, 2025. doi:10.1001/jam...
The findings, published Aug. 25 in theNew England Journal of Medicine, are based on more than 1,000 patients with MS, mostly the relapsing-remitting form. A small percentage had secondary progressive MS, a second phase of the disease that follows the relapsing-remitting years. About half were...
MS Patients Face Agonizing Wait For New MedicineSheryl Stolberg
Does Medicare Pay for Assisted Living? Assisted living offers support with daily tasks while promoting independence, but Medicare doesn't cover its costs. Explore other alternatives that may help cover some expenses. Paul WynnJan. 30, 2025
"This is different from, for example, neuro-oncology, where after probably a limited time, patients will pass away, and the same is true for some neuromuscular diseases. But with MS, there can be a prolonged period of suffering."
JAMA is launching an Insights series titled “Communicating Medicine” as a forum to introduce strategies for the clinician to improve communication of medicine and health-related topics to patients. The first in this series, “Strategies to Improve Medical Communication” by Cappola and Cohen, ...
Nature Medicine volume 7, pages 493–496 (2001)Cite this article 8379 Accesses 968 Citations 14 Altmetric Metrics details The molecular specificity and sensitivity of mass spectrometry (MS) has been employed in a new technology for direct mapping and imaging of biomolecules present in tissue ...
Mangesh Thorat, Research Fellow, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Ms. Carolyn Murphy, Operational Director, King’s Clinical Trials Unit, Kings College London, Ms. Ann Millman (patient representative), Oxford, Prof. Martin ...
Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece Nikolaos Papanas Department of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, Germany Roland E. Schmieder Clinical Research Services, Kiel, Germany Atef Halabi Forschergruppe...
The study by Dr. Amit Bar-Or at the Montreal Neurological Institute and Hospital and colleagues and published in the October issue ofScience Translational Medicine, provides groundbreaking insight into the role of B cells and their complex interaction with other immune cells in the context of MS....